Filing Details

Accession Number:
0000904454-16-001183
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-04-25 16:34:21
Reporting Period:
2016-04-21
Filing Date:
2016-04-25
Accepted Time:
2016-04-25 16:34:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1369786 Sagent Pharmaceuticals Inc. SGNT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1398936 Vivo Ventures V Affiliates Fund, L.p. 575 High Street. Suite 201
Palo Alto CA 94301
No No Yes No
1398937 Vivo Ventures Fund V, L.p. 575 High Street, Suite 201
Palo Alto CA 94301
No No Yes No
1399028 Vivo Ventures V, Llc 575 High Street, Suite 201
Palo Alto CA 94301
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-04-21 1,982 $13.55 2,978,803 No 4 S Indirect See footnote
Common Stock Disposition 2016-04-21 23 $13.55 34,961 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
No 4 S Indirect See footnote
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.55 to $13.57 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
  2. Includes 2,978,803 shares held of record by Vivo Ventures Fund V, L.P. ("Fund V") .Vivo Ventures V, LLC, the sole general partner of Fund V, may be deemed to be the beneficial owner of the shares held by Fund V. Vivo Ventures V, LLC hereby disclaims any beneficial ownership of any shares directly held by Fund V, except to the extent of its pecuniary interest therein.
  3. Includes 34,961 shares held of record by Vivo Ventures V Affiliates Fund, L.P. ("V Affiliates Fund"). Vivo Ventures V, LLC, the sole general partner of V Affiliates Fund, may be deemed to be the beneficial owner of the shares held by V Affiliates Fund. Vivo Ventures V, LLC hereby disclaims any beneficial ownership of any shares directly held by V Affiliates Fund, except to the extent of its pecuniary interest therein.